Results 101 to 110 of about 4,991 (157)

Comparative histopathological and immunological analysis of LRV2-positive and LRV2-negative Leishmania tropica in a BALB/c mouse cutaneous leishmaniasis model. [PDF]

Parasitol Res
Öztatlıcı M, Öztatlıcı H, Arserim SK, Balcıoğlu IC.   +3 more
europepmc   +1 more source

Response and therapeutic failure to meglumine antimoniate, the first-line drug for cutaneous leishmaniasis infections in Colombian soldiers. [PDF]

Parasitol Res
Pavia PX, Patiño LH, Méndez C, Romero Y, Duque MC, Cruz C, Ramírez JD.   +6 more
europepmc   +1 more source

Mycetoma-like cutaneous leishmaniasis. [PDF]

Rev Soc Bras Med Trop
Coimbra BZ, Espósito ACC, Carapeba MOL, Abreu MAMM.   +3 more
europepmc   +1 more source

An Investigation of Mucosal Leishmaniasis in the Military Health System. [PDF]

Mil Med
Pierre J, Davies J, Shaikh S, Hickey P.
europepmc   +1 more source

Don't Pack a Pest: Leishmania Guyanensis in Southwest Michigan. [PDF]

Cureus
Campbell SM, Furlan A, Dellatorre Diniz B, Costa Filho FF, Boamah H.   +4 more
europepmc   +1 more source

"High specificity of PCR in diagnosing mucocutaneous leshminiasis: a systematic review and meta analysis". [PDF]

BMC Infect Dis
Al-Dhubaibi MS, Bahaj SS, Noman A, Alkasser WY, AbdElneam AI, Mohammed GF, Nawaz H, Allana Z, Ali SS.   +8 more
europepmc   +1 more source

[Immunofluorescence in mucocutaneous leishmaniasis].

Anais brasileiros de dermatologia, 1969
R D, Azulay, M, Monteiro, E M, Vaz
openaire   +1 more source

Ambiguities in cutaneous leishmaniasis classification and the need for consensus: Experience from Ethiopia. [PDF]

PLoS Negl Trop Dis
van Henten S, Diro E, Tesfaye AB, Tilahun Zewdu F, van Griensven J, Enbiale W.   +5 more
europepmc   +1 more source

Mice mucosal leishmaniasis model shown high parasite load, increased cytotoxicity and impaired IL-10⁺ T cell response. [PDF]

Front Immunol
Da-Rocha AA, Dos-Santos JS, Bittencourt IS, De-Almeida DB, Manhães NCDS, Praxedes H, Romano JVP, da Silva-Junior EB, da Silva-Gonçalves AJ, Oliveira MP, Covre LP, Gomes DCO, Da-Cruz AM, da Fonseca-Martins AM, de Matos Guedes HL.   +14 more
europepmc   +1 more source

Editorial: Drug discovery for leishmaniasis and chagas disease: compound design and therapeutic strategies. [PDF]

Front Pharmacol
Kalesh K, Barbosa EG, Jordão AK.
europepmc   +1 more source